Admission Date:  [**2115-10-15**]              Discharge Date:   [**2115-10-19**]  Date of Birth:  [**2052-10-24**]             Sex:   M  Service: MEDICINE  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 613**] Chief Complaint: Pulmonary secretions, dyspnea  Major Surgical or Invasive Procedure: Bronchoscopy x3 with stent revision.
History of Present Illness: 62 year old male with stage IV NSCLC c/b tracheoesophageal fistula with Y stent and esophageal stent placement in [**6-18**] transferred from OSH with hypoxia and pneumonia.
On [**10-15**], patient was transferred to [**Hospital1 18**] as he had Y stent and esophageal stents placed here.
Past Medical History: Metastatic Lung Cancer (T9 met) Tracheoesophageal fistula s/p Y stent and esophageal stent [**6-18**] with stent revision [**2115-10-18**] Hypertension Small/stable pericardial effusion  Social History: lives with wife.
Physical Exam: T 98.4F  HR 113  BP 127/71  RR 20  98%/4L n.c. Gen: awake, alert, sitting upright in bed, NAD HEENT: PERRL, EOMI, anicteric, OP clear, MMM, cheeks flushed CV: S1, S2, RRR Pulm: Crackles left base Abd: (+) BS, soft, ND/NT, no rebound or guarding Ext: warm, well-perfused, no edema   Pertinent Results: [**2115-10-15**] 10:06PM   GLUCOSE-86 UREA N-14 CREAT-0.5 SODIUM-134 POTASSIUM-3.4 CHLORIDE-99 TOTAL CO2-21* ANION GAP-17 [**2115-10-15**] 10:06PM   CALCIUM-8.9 PHOSPHATE-2.9 MAGNESIUM-1.0* [**2115-10-15**] 10:00PM   WBC-9.4 RBC-2.49*# HGB-7.9* HCT-22.5*# MCV-90 MCH-31.7# MCHC-35.1* RDW-18.1* [**2115-10-15**] 10:00PM   NEUTS-91.8* BANDS-0 LYMPHS-4.5* MONOS-3.0 EOS-0.4 BASOS-0.3 [**2115-10-15**] 10:00PM   PLT SMR-LOW PLT COUNT-91*# [**2115-10-15**] 10:00PM   PT-13.3* PTT-25.7 INR(PT)-1.2* .
EGD [**2115-10-16**] The previously placed ultraflex stent was completely patent.
VIDEO OROPHARYNGEAL SWALLOW [**2115-10-18**] FINDINGS: An oral and pharyngeal swallowing video fluoroscopy study was performed in collaboration with the speech and swallow department.
Varying consistencies of barium were administered under constant fluoroscopic video guidance.
Patient demonstrated aspiration with continuous straw sips of thin liquids.
Esophageal and left bronchial stents are stable in position relative to [**9-24**].
Labwork on discharge: [**2115-10-19**] 09:50AM BLOOD WBC-3.4* RBC-2.94* Hgb-9.3* Hct-26.8* MCV-91 MCH-31.5 MCHC-34.6 RDW-17.3* Plt Ct-140* [**2115-10-19**] 05:10AM BLOOD Glucose-111* UreaN-8 Creat-0.8 Na-136 K-4.0 Cl-101 HCO3-25 AnGap-14  Brief Hospital Course: A/P: 62 yoM with stage IV NSCLC complicated by tracheoesophageal fistula s/p stents transferred from OSH with likely aspiration pneumonia and dysphagia.
The patient was empirically treated with vancomycin and zosyn for aspiration and hospital-acquired pneumonia.
The patient was discharged on levofloxacin per interventional pulmonology recommendations to complete a 14-day course when sensitivities returned on the bronchoalveolar cultures as above.
The patient was given supplemental oxygen and continued on nebulizers, guaifenesin and tessalon perles as needed.
Upper endoscopy showed patent stent as above.
The patient was followed by gastroenterology and speech and swallow during hospitalization.
The patient received three bronchoscopies with successful stent placement.
The patient was continued on pain control as needed.
The patient will return in [**4-18**] weeks for repeat bronchoscopy to assess stent position.
Treatment as above.
Albuterol 90 mcg/Actuation Aerosol Sig: 1-2 Puffs Inhalation every 4-6 hours as needed for shortness of breath or wheezing.
Codeine-Guaifenesin 10-100 mg/5 mL Syrup Sig: 5-10 MLs PO Q6H (every 6 hours) as needed for cough.
Benzonatate 100 mg Capsule Sig: One (1) Capsule PO TID (3 times a day) as needed for cough.
Levofloxacin 500 mg Tablet Sig: One (1) Tablet PO once a day for 10 days.
Oxycodone 5 mg/5 mL Solution Sig: 5-10 mg PO Q4-6H (every 4 to 6 hours) as needed.
Fentanyl 100 mcg/hr Patch 72HR Sig: One (1) Patch 72HR Transdermal Q72H (every 72 hours).
Ipratropium Bromide 17 mcg/Actuation Aerosol Sig: 1-2 Puffs Inhalation every 4-6 hours as needed for shortness of breath or wheezing.
Secondary: Metastatic Lung Cancer (T9 met) Tracheoesophageal fistula s/p Y stent and esophageal stent [**6-18**] with stent revision [**2115-10-18**] Hypertension Small/stable pericardial effusion   Discharge Condition: Afebrile, vital signs stable.
Please take your medications as prescribed.
You have been given prescriptions for albuterol and ipratropium inhalers and cough suppressents as needed.
You should call Interventional Pulmonology at [**Telephone/Fax (1) 3020**] about returning in [**4-18**] weeks for repeat bronchoscopy to reevaluate stent placement.
